Viral Vector-Mediated Gene Therapy for Hemophilia

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|1|3|301-315

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.1, Iss.3, 2001-09, pp. : 301-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System

By Pérez-Martínez Francisco   Guerra Javier   Posadas Inmaculada   Ceña Valentín  

Pharmaceutical Research, Vol. 28, Iss. 8, 2011-08 ,pp. : 1843-1858

Springer Publishing Company

Access to resources Recommend Favorite

The Potential of Viral Vector-Mediated Gene Transfer to Prolong Corneal Allograft Survival

By  

Current Gene Therapy, Vol. 9, Iss. 1, 2009-02 ,pp. : 33-44

Bentham Science Publishers

Access to resources Recommend Favorite

Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy

By  

Current Gene Therapy, Vol. 1, Iss. 2, 2001-07 ,pp. : 149-162

Bentham Science Publishers

Access to resources Recommend Favorite

Retroviral Vector-mediated Gene Therapy for Metabolic Diseases: An Update

By  

Current Pharmaceutical Design, Vol. 17, Iss. 24, 2011-08 ,pp. : 2516-2527

Bentham Science Publishers

Access to resources Recommend Favorite

Cystic Fibrosis, Vector-Mediated Gene Therapy, and Relevance of Toll-Like Receptors: A Review of Problems, Progress, and Possibilities

By  

Current Gene Therapy, Vol. 8, Iss. 3, 2008-06 ,pp. : 201-207

Bentham Science Publishers

Access to resources Recommend Favorite